EUVIMEDEUVIMED entdecken
Fall-Kontroll-Studie

Metformin Use and Risk of Non-Melanoma Skin Cancer: A Propensity-Matched Case-Control Study

Zaim Haq, Fatima N Mirza, Parsa Abdi, Michael J Diaz, Tiffany J Libby

Journal of Drugs in Dermatology · 2024

DOI: 10.36849/jdd.8249 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift Journal of Drugs in Dermatology, 2024. Verfasst von Zaim Haq und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Metformin, Skin Neoplasms, Basal Cell Carcinoma, Propensity Score. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminSkin NeoplasmsBasal Cell CarcinomaPropensity ScoreCarcinoma, Squamous CellHumansMaleFemaleRetrospective StudiesCase-Control StudiesMiddle AgedAgedHypoglycemic AgentsIncidenceUnited StatesAdultRisk Factors

Substanzen

MetforminHypoglycemic Agents

Zitieren

APA

Haq, Z., Mirza, F. N., Abdi, P., Diaz, M. J., & Libby, T. J. (2024). Metformin Use and Risk of Non-Melanoma Skin Cancer: A Propensity-Matched Case-Control Study. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.8249

Vancouver

Haq Z, Mirza FN, Abdi P, Diaz MJ, Libby TJ. Metformin Use and Risk of Non-Melanoma Skin Cancer: A Propensity-Matched Case-Control Study. Journal of Drugs in Dermatology. 2024. doi:10.36849/jdd.8249

BibTeX
@article{Haq2024,
  author = {Haq, Zaim and Mirza, Fatima N and Abdi, Parsa and Diaz, Michael J and Libby, Tiffany J},
  title = {Metformin Use and Risk of Non-Melanoma Skin Cancer: A Propensity-Matched Case-Control Study},
  journal = {Journal of Drugs in Dermatology},
  year = {2024},
  doi = {10.36849/jdd.8249}
}
Kostenlos starten →